AI Noise Reduction in Phonak Hearing Aids

Last updated: June 10, 2025
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hearing Impairment

Hearing Loss

Deafness

Treatment

DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction

Clinical Study ID

NCT06743295
24-009408
  • Ages 18-110
  • All Genders

Study Summary

The purpose of this study is to determine if artificial intelligence- based noise reduction can offer objective improvement in hearing and speech perception for hearing impaired patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with hearing impairment not using hearing aids

  • Individuals with hearing impairment currently using hearing aids

  • Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)

Study Design

Total Participants: 500
Treatment Group(s): 1
Primary Treatment: DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip Artificial intelligence-based noise reduction
Phase:
Study Start date:
April 24, 2025
Estimated Completion Date:
January 01, 2026

Connect with a study center

  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.